Kereena Chukka, et al. “Study on CD44 As a Cancer Stem Cell Marker for Head and Neck Squamous Cell Carcinoma”. Highlights on Medicine and Medical Science Vol. 12, July 2021, pp. 118-23, doi:10.9734/bpi/hmms/v12/10882D.